| Previous close | 0.6000 |
| Open | 0.6000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 2.50 |
| Expiry date | 2024-09-20 |
| Day's range | 0.5000 - 0.6500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- GuruFocus.com
Esperion Therapeutics Inc (ESPR) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues ...
Discover how Esperion Therapeutics achieved a historic revenue milestone and expanded market potential in its first quarter of 2024.
- GuruFocus.com
Esperion Therapeutics Inc (ESPR) Surpasses Q1 Revenue Forecasts with a 467% Increase
Significant Growth and FDA Approvals Propel Performance
ZacksEsperion Therapeutics (ESPR) Q1 Earnings and Revenues Beat Estimates
Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of 525% and 159.32%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.